Literature DB >> 17693525

Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors for early disease onset.

Ralf Zarbock1, Doris Hendig, Christiane Szliska, Knut Kleesiek, Christian Götting.   

Abstract

BACKGROUND: Pseudoxanthoma elasticum (PXE) is a rare hereditary disorder characterized by progressive calcification and fragmentation of elastic fibers in connective tissues. PXE is caused by mutations in the ABCC6 gene, which encodes the membrane transporter multidrug resistance-associated protein 6. Chronic oxidative stress was recently suggested to play a crucial role in the pathogenesis of the disease. Our aim was to investigate the association of PXE with genetic variation in genes coding for antioxidant enzymes.
METHODS: We used restriction fragment length polymorphism and allele-specific PCR analyses to evaluate the distribution of single-nucleotide polymorphisms in the genes encoding catalase (CAT), superoxide dismutase 2 (SOD2), and glutathione peroxidase 1 (GPX1) in DNA samples from 117 German PXE patients and 117 healthy age- and sex-matched control individuals.
RESULTS: The investigated genetic variants had previously been shown to affect the activities of these antioxidant enzymes. We found a correlation between genotype and age of disease onset for polymorphisms in CAT (c.-262C>T), SOD2 (c.47C>T), and GPX1 (c.593C>T). Furthermore, the age of disease onset was inversely correlated with the number of mutated alleles, indicating a cumulative effect on the time of disease onset [mean (SD) age of 40.9 (13.6) years, 32.4 (16.3) years, and 25.7 (15.9) years for carriers of 0, 1-2, and >2 mutated alleles, respectively; P = 0.03].
CONCLUSION: Our findings demonstrate that increased oxidative stress due to activity-affecting polymorphisms in genes encoding antioxidant enzymes leads to earlier PXE onset.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693525     DOI: 10.1373/clinchem.2007.088211

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  22 in total

Review 1.  ABCC6 as a target in pseudoxanthoma elasticum.

Authors:  András Váradi; Zalán Szabó; Viola Pomozi; Hugues de Boussac; Krisztina Fülöp; Tamás Arányi
Journal:  Curr Drug Targets       Date:  2011-05       Impact factor: 3.465

2.  Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients.

Authors:  Ulf Diekmann; Ralf Zarbock; Doris Hendig; Christiane Szliska; Knut Kleesiek; Christian Götting
Journal:  J Mol Med (Berl)       Date:  2009-07-03       Impact factor: 4.599

3.  Modifier genes in pseudoxanthoma elasticum: novel insights from the Ggcx mouse model.

Authors:  Alain Hovnanian
Journal:  J Mol Med (Berl)       Date:  2010-02-11       Impact factor: 4.599

Review 4.  Pseudoxanthoma elasticum: progress in diagnostics and research towards treatment : Summary of the 2010 PXE International Research Meeting.

Authors:  Jouni Uitto; Lionel Bercovitch; Sharon F Terry; Patrick F Terry
Journal:  Am J Med Genet A       Date:  2011-06-10       Impact factor: 2.802

5.  Magnesium carbonate-containing phosphate binder prevents connective tissue mineralization in Abcc6(-/-) mice-potential for treatment of pseudoxanthoma elasticum.

Authors:  Qiaoli Li; Jennifer Larusso; Alix E Grand-Pierre; Jouni Uitto
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

Review 6.  Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms.

Authors:  Qiaoli Li; Qiujie Jiang; Ellen Pfendner; András Váradi; Jouni Uitto
Journal:  Exp Dermatol       Date:  2008-10-22       Impact factor: 3.960

7.  Clinical and histopathological characteristics of a family with R1141X mutation of pseudoxanthoma elasticum - presymptomatic testing and lack of carrier phenotypes.

Authors:  Gulsen Akoglu; Qiaoli Li; Ozay Gokoz; Ali Serhan Gazyagci; Jouni Uitto
Journal:  Int J Dermatol       Date:  2013-05-15       Impact factor: 2.736

8.  The mineralization phenotype in Abcc6 ( -/- ) mice is affected by Ggcx gene deficiency and genetic background--a model for pseudoxanthoma elasticum.

Authors:  Qiaoli Li; Jouni Uitto
Journal:  J Mol Med (Berl)       Date:  2009-09-27       Impact factor: 4.599

9.  Pseudoxanthoma elasticum is a metabolic disease.

Authors:  Qiujie Jiang; Masayuki Endo; Florian Dibra; Krystle Wang; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2008-08-14       Impact factor: 8.551

10.  CAT C-262T and GPX1 Pro198Leu polymorphisms in a Turkish population.

Authors:  H Sinan Suzen; Emel Gucyener; Ozgul Sakalli; Zuhal Uckun; Gulcin Kose; Duygu Ustel; Yalcin Duydu
Journal:  Mol Biol Rep       Date:  2009-05-08       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.